Product Program year 2023 Source: CMS Open Payments

Infasurf

Drug Product

Open in the dashboard

General payments

$81,817

65 payments

Research payments

$128,037

27 payments

Through program year 2023, $81,817 in general payments and $128,037 in research payments were reported against Infasurf (Product).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $27,504 38
2020 General $54,313 27
2020 Research $128,037 27

Breakdown

Who paid General payments · program years 2020–2023
  1. ONY Biotech Inc. $81,817 65 payments
Top recipients General payments · program year 2023
  1. Scott Guthrie Neonatal-Perinatal Medicine · Nashville, TN $20,255 74% · 10 payments
  2. Dinushan Kaluarachchi Neonatal-Perinatal Medicine · Madison, WI $3,980 14% · 8 payments
  3. Kari Roberts Neonatal-Perinatal Medicine · Minneapolis, MN $1,070 4% · 4 payments
  4. Stephen Minton Neonatal-Perinatal Medicine · Provo, UT $633 2% · 5 payments
  5. Prem Fort Neonatal-Perinatal Medicine · St Petersburg, FL $283 1% · 2 payments

The top 5 of 14 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Neonatal-Perinatal Medicine Pediatrics $27,149 99% · 11 practitioners
  2. Pediatrics $280 1% · 2 practitioners
  3. Pediatric Critical Care Medicine Pediatrics $76 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Tennessee $20,255 74% · 1 recipient
  2. Wisconsin $3,980 14% · 1 recipient
  3. Minnesota $1,070 4% · 1 recipient
  4. Utah $840 3% · 2 recipients
  5. Florida $402 1% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

65 general · 27 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record